They demonstrated that menin inhibition induced the loss of MEIS1 expression and led to the significant differentiation of Npm1c leukemic cells in vitro, with a potent anti-leukemic activity on NPM1c in pre-leukemia and in overt leukemia. The gene discussed is MEIS1; the disease is leukemia.